Drug Type Bispecific antibody |
Synonyms STAR 003, STAR-003 |
Target |
Action modulators |
Mechanism TCR modulators(T-cell receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | United States | 02 Aug 2022 |